Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 123745
Published online Sep 15, 2026. doi: 10.4251/wjgo.123745
Published online Sep 15, 2026. doi: 10.4251/wjgo.123745
Figure 4 Transglutaminase 2 overexpression enhances colorectal cancer cell proliferation.
A: Circular plasmid map of lentiviral vector pLV3-CMV-TGM2 (human)-5-Puro; B and C: Western blot was used to detect the expression levels of transglutaminase 2 protein levels in HCT116 (B) and CACO-2 (C) cells; D and E: Representative image of colony formation assays of HCT116 (D) and CACO-2 (E) cells; F and G: EdU staining was performed to detect the proliferation of HCT116 (F) and CACO-2 (G) cells (scale bar: 50 μm). Error bars represented the mean ± SEM. aP < 0.01, bP < 0.001. TGM2: Transglutaminase 2.
- Citation: Chen YZ, Liu J, Wang YP, Du J, Ma JC, Jin GS. EPZ020411, a PRMT6 inhibitor, suppresses colorectal cancer cell proliferation, migration, and invasion through targeting the TGM2/MAPK axis. World J Gastrointest Oncol 2026; 18(9): 123745
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/123745.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123745